177Lu - Oncidium Foundation

Lu-177-Debio-1124

177Lu-Debio 1124 is a second-generation radiolabeled peptide analogue of minigastrin [...]

support dev2023-07-10T07:54:12+00:00

177Lu-DOTA-EB-TATE is a therapeutic agent based on the peptide octreotate [...]

support dev2022-10-10T18:44:02+00:00

177Lu-EB-PSMA-617 is a PSMA-617 analogue developed in China as an [...]

support dev2022-10-10T18:55:52+00:00

177Lu-PSMA-R2 was developed as patent protected equivalent of 177Lu-PSMA-617. This [...]

support dev2022-10-10T19:17:39+00:00

177Lu-DTPA-Omburtamab (177Lu-Burtomab) is a monoclonal murine antibody, targeted against [...]

support dev2022-10-10T18:52:49+00:00

177Lu-RM2 (177Lu-BAY-1017858) is a molecule corresponding to a different [...]

support dev2022-10-10T19:22:49+00:00

177Lu-PNT2002 (formerly 177Lu-PSMA-I&T) is a peptide developed by the [...]

support dev2022-12-14T13:23:57+00:00